CymitQuimica logo

CAS 159426-95-6

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
  • Carvedilol Impurity 32

    CAS :
    Formule :C24H26N2O5
    Couleur et forme :Off-White Solid
    Masse moléculaire :422.48

    Ref: 4Z-C-0224

    5mg
    À demander
    10mg
    1.942,00€
    25mg
    3.580,00€
    50mg
    5.764,00€
    100mg
    À demander
  • 8-Hydroxy Carvedilol-d3

    Produit contrôlé
    CAS :
    Formule :C24D3H23N2O5
    Couleur et forme :Neat
    Masse moléculaire :425.492

    Ref: TR-H825012

    75mg
    14.624,00€
  • (R)-(+)-8’Hydroxy Carvedilol

    Produit contrôlé
    CAS :
    Formule :C24H26N2O5
    Couleur et forme :Neat
    Masse moléculaire :422.47

    Ref: TR-H825920

    50mg
    8.684,00€
  • 8-Hydroxy carvedilol

    CAS :
    8-Hydroxy carvedilol is an analog of the beta-blocker drug carvedilol that has been shown to have potent anticancer properties. It inhibits the activity of protein kinase C (PKC), which is involved in cell signaling pathways that regulate cell growth and survival. 8-Hydroxy carvedilol has been found to induce apoptosis in human and Chinese hamster ovary cells, as well as in tumor cells from various types of cancer. This drug also inhibits the activity of calcitonin gene-related peptide (CGRP), a neuropeptide that is involved in pain transmission and inflammation. In addition, 8-Hydroxy carvedilol has been shown to inhibit oxytocin-induced contractions in isolated rat uterus tissue. Overall, these findings suggest that 8-Hydroxy carvedilol may have potential as a novel anticancer agent with anti-inflammatory properties.
    Formule :C24H26N2O5
    Degré de pureté :Min. 95%
    Masse moléculaire :422.5 g/mol

    Ref: 3D-JGA42695

    5mg
    1.032,00€
    10mg
    1.354,00€
    25mg
    2.472,00€
    50mg
    3.954,00€
  • 8-Hydroxy Carvedilol

    CAS :
    Formule :C24H26N2O5
    Masse moléculaire :422.48

    Ref: ST-EA-CP-C10045

    10mg
    À demander
    25mg
    À demander
    50mg
    À demander
    100mg
    À demander